热门搜索:A549    293T 金黄色葡萄球菌 大肠杆菌 AKK菌
购物车 1 种商品 - 共0元
当前位置: 首页 > ATCC代理 > Acinetobacter baumannii Bouvet and Grimont
最近浏览历史
联系我们
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省宁波市镇海区庄市街道兴庄路9号
  • 创e慧谷42号楼B幢401室
Acinetobacter baumannii Bouvet and Grimont
Acinetobacter baumannii Bouvet and Grimont
规格:
货期:
编号:B161436
品牌:Mingzhoubio

标准菌株
定量菌液
DNA
RNA

规格:
冻干粉
斜面
甘油
平板


产品名称 Acinetobacter baumannii Bouvet and Grimont
商品货号 B161436
Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Acinetobacter baumannii
Verified By Whole-genome Sequencing
Strain Designations 1125209
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation Sputum
Isolation Date 2014
Geographic Source Italy
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -80°C or colder
Preceptrol® no
Annotated Genes AAC(6')-Ib7
ADC-2
aadA
adeA
adeB
adeC
adeF
adeG
adeI
adeJ
adeK
adeR
adeS
APH3-Ia
APH(3'')-Ib
APH(3')-VIa
APH(6)-Id
armA
catB8
macA
macB
mexB
mexK
msrE
OXA-23
OXA-66
tet(A)
Type Strain no
MIC Range Susceptible
Colistin: ≤2 µg/mL


Resistant
Amikacin: ≥64 µg/mL
Cefepime: ≥32 µg/mL
Ceftazidime: ≥32 µg/mL
Ceftriaxone: ≥64 µg/mL
Ciprofloxacin: ≥4 µg/mL
Doripenem: ≥8 µg/mL
Imipenem: ≥8 µg/mL
Levofloxacin: ≥8 µg/mL
Meropenem: ≥8 µg/mL
Piperacillin-tazobactam: ≥128/4 µg/mL
Tetracycline: ≥16 µg/mL


Comments This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor International Health Management Associates (IHMA), Inc.
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- International Health Management Associates (IHMA), Inc.
Patient Age 73
Patient Gender Male
References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.

梅经理 17280875617 1438578920
胡经理 13345964880 2438244627
周经理 17757487661 1296385441
于经理 18067160830 2088210172
沈经理 19548299266 2662369050
李经理 13626845108 972239479